Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy with Cisplatin +/- Gemcitabine in Cervical Cancer
NCT00842660Phase 3Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gemcitabine in Cervical Cancer (CC) (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoints: Overall Survival and Progression-Free Survival. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00842660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842660.